DnaNudge provides personalized, DNA-based recommendations to help customers make healthier product choices while shopping. The service offers insights based on genetic traits related to nutrition, skincare, and activity.

DnaNudge

DNANUDGE | 6,788 followers on LinkedIn. Nudging your everyday choices through your DNA plus your lifestyle. Buy in-store and online now. | DnaNudge is the developer of the world’s first service to use consumers’ own DNA plus lifestyle factors to nudge people towards healthier choices while shopping. The DnaNudge service analyses and maps users’ genetic profile to key nutrition-related health traits such as obesity, diabetes, hypertension and cholesterol, enabling customers to be guided by their DNA towards healthier eating. The service has been developed by world-renowned biomedical engineer Regius Professor Chris Toumazou FRS and published geneticist Dr Maria Karvela.

VP, Assay Development at DNANUDGE LIMITED

Rashmita Sahoo

CTO at TSC - Connected Care (Sensium Healthcare, CareXS)

Alison Burdett

Senior Scientist at DNANUDGE

Sara de Mateo López

Executive Vice President of Digital at DNANUDGE

Tsz-Kin (TK) Hon

DNANUDGE

📣NEWS: Imperial College London reports that a UK trial with DNANUDGE has found that a DNA-tailored diet could help manage blood glucose and reduce risk of progressing to type 2 diabetes in high-risk individuals. The pilot study found that following personalised dietary advice informed by genetic information - in combination with face-to-face dietary coaching from a healthcare professional - was more effective at reducing blood glucose levels than standard dietary coaching based on the National Institute for Health and Care Excellence (NICE) guidelines, which are the current standard of care in the UK. The results have been published in Nature Scientific Reports. Joint senior author Professor Nick Oliver , a clinical consultant in diabetes and endocrinology from Imperial College London’s Department of Metabolism, Digestion and Reproduction: “Prior to progression to type 2 diabetes, people and their healthcare professionals have an opportunity to reduce their risk. The NICE guidance for lifestyle change – for example, the inclusion of fruits, vegetables, healthy fats and whole grains – are evidence based and effective for a population, but our findings suggest that personalisation by genetically tailoring dietary advice to an individual might have an even greater effect.” Joint senior author Regius Professor Chris Toumazou , from Imperial College London’s Department of Electrical and Electronic Engineering and DnaNudge: “Genetic profiles of chronic conditions, such as type 2 diabetes, obesity, hypertension, and blood cholesterol can tell us which foods might be better or worse at reducing the risk of these conditions, allowing us to specifically tailor advice around their dietary intake of fats, carbohydrates, and other macronutrients. Our pilot study, where we apply this to pre-diabetes, shows promising results, suggesting that genetically-informed diets could be an effective intervention compared to, or combined with, standard NICE-guided advice.” Joint first author Dr Dr Maria Karvela, PhD , from Imperial College London’s Department of Electrical and Electronic Engineering and DnaNudge: “Though clinical research into personalised nutrition and type 2 diabetes is still developing, our study adds to evidence that supports the value of such personalised approaches. If validated, our intervention could provide a cost-effective, widely distributable, and easily scalable prevention tool for improving glucose regulation in high-risk individuals.” Full story here: https://lnkd.in/erk_D6H5 #DnaNudge #Imperial #diabetes #genetics #nutrition #T2DM

📣UPCOMING: Hear from our co-founder and CSO Dr Maria Karvela FRSB at L.A. Times B2B Publishing 's Inspirational Women Forum & Leadership Awards. Registration open now ⬇

Have you checked out our incredible Product Categories finalists in the Elektra Awards 2024? Come and join us on Tuesday 10 December 2024, at the iconic IET London, Savoy Place to see who will be crowned the winners. Secure your table now: bit.ly/Elektra24-tickets With many thanks to our Product Category partners: Swindon Silicon Systems , Rochester Electronics, LLC and WIN SOURCE . Huge congratulations to all finalists and best of luck! Analog Devices , ENNOVI , Microchip , Molex , Renesas Electronics , AllSpice , Percepio® , RUTRONIK Electronics Worldwide , Siemens , Synopsys Inc , The Embedded Kit Advantech Europe , DNANUDGE , Eskan Electronics, Taoglas , Same Sky , Empower Semiconductor , Murata , The Optoelectronic Manufacturing Corporation (uk) Limited , OMRON Electronic Components Europe B.V. , Panasonic Industry Europe , Pickering Electronics , Vishay Intertechnology, Inc. , Eggtronic , Innoscience , Navitas Semiconductor , QPT , SemiQ, Silicon Labs , Smiths Interconnect , Vicor XP Power , EPC - Efficient Power Conversion , Impinj , MELEXIS , NOVELDA , Phlux Technology - more finalists to be continued in the comments. #ElektraAwards2024 #ElektraAwards #electronics

Electronics Weekly

NEWS: Our co-founder and President of Technology Professor Chris Toumazou shares a special message to celebrate the 20th anniversary edition of the IEEE Biomedical Circuits and Systems (BioCAS) conference, currently taking place in Xi’an, China. Professor Toumazou was one of the founders and pioneers of this key IEEE group, which offers a unique international forum for presenting interdisciplinary research and development activities at the crossroads of medicine, life sciences, physical sciences and engineering that is shaping tomorrow's medical devices and healthcare systems. #IEEEBioCAS #biomedical #electronics #medtech #healthtech

📢 DNANUDGE is profiled in the latest Seedtable ranking: 69 Best Health Tech Startups in London to Watch in 2024 🚀 Full list 🔗 https://lnkd.in/gcvsCQpY #DnaNudge #medtech #healthtech #genetics #diagnostics

NEWS: The DNANUDGE team was proud this week to celebrate 5 Years of Innovation with Chelsea and Westminster Hospital NHS Foundation Trust 🚀🎉 We were delighted to join the CW Innovation 5 Year Anniversary Event yesterday, where we had the opportunity to showcase our DNANUDGE consumer genetics and diagnostics technology. The innovation programme - led by Chelsea and Westminster Hospital NHS Foundation Trust and its charitable arm CW+ charity - has offered a groundbreaking and invaluable platform for testing disruptive innovations and novel technologies in real-world settings. A huge thank you to the inspiring speakers, including: 🔹CW+'s Chris Chaney , who shared insights on the programme’s journey, emphasising how true innovation stems from adopting new perspectives 🔹Lesley Watts, who highlighted the importance of behavioural shifts and empowering clinicians to drive innovation 🔹Caroline Clarke, who spoke passionately about the vision of making London the healthiest city in the world and building infrastructures that promote continuous innovation We also heard from forefront innovation champions Sadia Khan , Sara Nelson , Thomas Whicher , Bruno Botelho and Dr Anas Nader , whose contributions are shaping the future of healthcare. Here’s to many more years of collaboration, innovation, and transforming healthcare for the better🌟 Professor Chris Toumazou | Dr Maria Karvela FRSB | Paul Lester #healthcare #digitalhealth #healthinnovation #medtech #healthtech

📣UPCOMING: Hear insights from our co-founder and Chief Scientific Officer Dr Maria Karvela FRSB at the 2024 Inspirational Women & Leadership Awards, hosted by L.A. Times B2B Publishing . 🗓️Thursday November 14th 2024 🕕12.30 - 8.30pm PST 📍InterContinental Los Angeles Downtown #healthtech #medtech #consumergenetics #womenleaders

🔎Artificial Intelligence in Personalized Food Recommendations: Key Leaders in the Consumer Industry 🤖 As AI continues to shape the future of the consumer industry, personalized food recommendation systems have emerged as a key innovation area. These systems use individual data such as dietary goals, health status, allergies and food preferences to offer tailored food suggestions — from simple recipe apps to advanced virtual shopping experiences. A GlobalData Plc 's Patent Analytics shows some key players driving innovation in this space: ➡️ Baxter International Inc. , Panasonic and DNANUDGE , leading in patent filings related to personalized food recommendations ➡️ DNAnudge partners with Holland & Barrett to offer DNA-personalized services, promoting healthier eating based on genetic profiles ➡️ Maxingvest leads in application diversity, with Shiseido and DNAnudge following ➡️ Baxter International also ranks highest in geographic reach 🚀 With the increasing focus on personalized nutrition, companies that leverage AI to deliver custom food recommendations are poised to thrive in this growing market. We look forward to welcoming countless innovative companies and aspiring startups to Anuga 2025! #PersonalizedNutrition #AI #WeAreAnuga

Anuga

We’re #hiring a new Mobile App Developer (Android) MAT Cover in London Area, United Kingdom. Apply today or share this post with your network.

NEWS: We are thrilled to have been named a finalist in the prestigious Electronics Weekly Elektra awards 2024! 🎉 We have been honoured by the judges in the Excellence in Product Design Award (High-Reliability Systems, including Medical) for our world's first 20-minute retail Express DNA test - now available exclusively at selected Holland & Barrett stores. The annual Elektra Awards recognise exceptional companies and individuals have demonstrated unparalleled excellence, dedication, and innovation in their field, not only embracing the challenges posed by the industry but rising above and pushing the boundaries to set new standards. The winners will be announced at a gala awards ceremony on Tuesday 10th December 2024 at Institution of Engineering and Technology (IET) London, Savoy Place. Congratulations and good luck to all of the finalists - full list here: https://lnkd.in/gN2sNfTr #ElektraAwards #electronics

Metric
Company Name	DnaNudge
Symbol
MSH ID	COM:DNANUDGE
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	GB
Stage
Employee Count
Website	dnanudge.com
LinkedIn	dnanudge
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

DNAN

COM:DNANUDGE

DnaNudge

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue